How to stop an autocrat
What can Americans learn from the citizens of Brazil, Poland, and South Korea who defeated the dragons threatening their democracies?
Trump administration resumes student loan collections, threatening millions with garnished wages and economic hardship
Restarting federal loan garnishments and ending relief programs, the Trump administration advances a sweeping overhaul that critics say punishes struggling borrowers and deepens a national crisis.
No putz has offended more millions in more places, more quickly—with no tipping point...
The Trump Horror Show is the fastest growing American “export commodity” – jeopardizing hundreds of billions in lost tourist dollars, lost foreign student tuitions, and lost confidence in American trustworthiness.
Trump administration dismantles pollution protections and deletes public data as EPA grants sweeping exemptions...
Environmental groups sue over deletion of climate and justice tools while polluters receive fast-tracked exemptions from EPA oversight.
Trump harvests autocratic powers
Planted by Bush and Cheney.
Facing Trump’s America
As we experience Donald Trump’s twenty-first-century version of White nationalism, how we dealt with that difficult past should help us remember that we lived through terrible times by confronting them and that we can do so again.
The disintegration of North America
Director Michael Moore was trying to satirize the U.S. penchant for invading other countries.
Democrats push to ban congressional stock trading amid tariff-triggered market scandal
Lawmakers intensify calls to outlaw stock trades by members of Congress following Trump’s tariff reversal and suspicious GOP investments.
It’s time for ‘unified groups’ to declare war against Trump’s unscrupulous retribution schemes
They must use all the innovative techniques that they have to take down Trump before he turns them into his slaves, and America into a fascist state.
Trump executive order hands Big Pharma a major win by delaying Medicare drug price...
Order pushes for four-year delay in Medicare price talks for most prescription drugs, echoing pharma lobby demands and risking higher costs for patients.